Q4 2022 Holdings
Filed 2023-02-14 | 64 holdings | $1.1B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2023-11-08) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $12.3M | 2,200,999 | 1.1% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $12.4M | 254,586 | 1.1% |
| Avantor Inc(AVTR) | COM | 05352A100 | $12.7M | 600,200 | 1.1% |
| Icon PLC(ICLR) | SHS | G4705A100 | $13.0M | 66,693 | 1.1% |
| Elevance Health Inc | COM | 036752903 | $14.4M | 28,042 | 1.3% |
| Haleon PLC(HLN) | SPON ADS | 405552100 | $15.1M | 1,881,470 | 1.3% |
| Centene Corp del(CNC) | COM | 15135B101 | $17.6M | 214,561 | 1.5% |
| Spdr SER TR(XBI) | S&P BIOTECH | 78464A870 | $17.9M | 216,087 | 1.6% |
| GSK PLC | CALL | 37733W904 | $19.8M | 20,937 | 1.8% |
| Envista Holdings Corporation(NVST) | COM | 29415F104 | $21.6M | 642,405 | 1.9% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $24.9M | 558,774 | 2.2% |
| Illumina Inc(ILMN) | COM | 452327109 | $28.3M | 140,067 | 2.5% |
| Catalent Inc(CTLTEUR) | COM | 148806102 | $31.1M | 691,677 | 2.7% |
| Biogen Inc(BIIB) | COM | 09062X103 | $38.0M | 137,348 | 3.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $41.2M | 1,620,713 | 3.6% |
| Teva Pharmaceutical Inds LTD(TEVA) | SPONSORED ADS | 881624209 | $43.0M | 4,712,597 | 3.8% |
| Danaher Corporation(DHR) | COM | 235851102 | $43.2M | 162,571 | 3.8% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $64.7M | 232,787 | 5.7% |
| GSK PLC(GSK)CallA | SPONSORED AD | 37733W204 | $73.6M | 2,093,700 | 6.4% |
| Sanofi(SNY) | SPONSORED ADR | 80105N105 | $77.7M | 1,603,348 | 6.8% |
| Natera Inc(NTRA) | COM | 632307104 | $107.9M | 2,685,959 | 9.5% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $121.1M | 1,064,446 | 10.6% |
| GSK PLC(GSK) | SPONSORED ADR | 37733W204 | $123.8M | 3,490,457 | 10.8% |